bioRxivImmunologyPreprint
Polyfunctional pathogen-specific CD4+ T cells reside in the lungs and tumors of NSCLC patients
A. E. Oja, F. Morgana, R. Hagen, C. A. Ghandour, M. A. Nolte, S. Rooijakkers, R. A. W. van Lier, B. W. Bardoel, P. Hombrink
Abstract
Local T cell responses are required for optimal protection of the lungs against airborne pathogens. This localized protection is mediated by various immune cells, including resident memory T cells (TRM). While human lung CD8+ TRM line the epithelium and are enriched for recognition of respiratory viruses, we found CD4+ TRM to exhibit more heterogeneous localization patterns, surrounding airways, forming clusters in the lung parenchyma, and lining the epithelium. This heterogeneity was also reflected functionally, as lung CD4+ TRM were enriched for recognition of diverse classes of respiratory pathogens. Upon stimulation, lung CD4+ TRM expressed different polyfunctional cytokine profiles depending on the pathogen recognized. CD4+ TRM responding to respiratory viruses and bacteria were biased for production of IFN-{gamma} and IL-17, respectively. Strikingly, pathogen-specific CD4+ TRM also represent a significant fraction in NSCLC tumors that remained polyfunctional despite high PD-1 expression. These findings are not only important for vaccine design, but also provide a rationale for reinvigorating anti-tumor immunity through triggering of polyfunctional pathogen-specific CD4+ tumor infiltrating lymphocytes.
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Specific dendritic cells spatial organization is associated to ICB Response in Non Small Cell Lung Cancer (NSCLC)
Élisa Gobbini, Pierre Duplouye, … Jenny Valladeau‐Guilemond·bioRxiv·May 7, 2026
- Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile
R. de Groot, M. M. van Loenen, … M. C. Wolkers·bioRxiv·Jun 8, 2019
- Common origin for effector and regulatory Follicular and Tissue-Adapted CD4+ T cells in Non-Small Cell Lung Cancer
Jimena Tosello, Wilfrid Richer, … Eliane Piaggio·bioRxiv·Sep 17, 2025
- Differential predictive value of resident memory CD8+T cell subpopulations in non-small-cell lung cancer patients treated by immunotherapy
L. Paolini, T. Tran, … E. TARTOUR·bioRxiv·Mar 7, 2024
- Functional systemic CD4 immunity is a differential factor for clinical responses to PD-L1/PD-1 blockade therapy in lung cancer
M. Zuazo, H. Arasanz, … D. Escors·bioRxiv·Jan 9, 2019
- Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in non-small cell lung cancer patients
C. Metoikidou, P. Gueguen, … S. Amigorena·bioRxiv·Aug 14, 2020